Home › Core › ISCC-IDs › 28CrZjiRtXeqs

View ISCC-ID

Core Data

28CrZjiRtXeqs
ISCC-ID - digital asset identifier
CCfh3Bp9274wh-CTcikr1ori59a-CDWWfUbbmzgmW-CRdA9CVPoaLsW
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

safety and efficacy of firstline treatments for chemotherapynaive metastatic castrationresistant prostate cancer a systematic re

Ledger Reference

coblo
Source Ledger/Blockchain
646580
N-th ISCC Decleration on source ledger
7dcb59e1b29ab649953ad7a6c4e0ac392e3481ef05daeeae8c7fc06235aa9f60
Hash of block that includes the ISCC-DECLARATION
b9403a11255bbfe02e3897a9e4488a05eec67b4ff148ad4d6149d8835ce7702d
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Safety and Efficacy of First-Line Treatments for Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Indirect Comparison", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Haofeng Zheng", "@type": "Person"}, {"name": "Jialiang Chen", "@type": "Person"}, {"name": "Wenhan Qiu", "@type": "Person"}, {"name": "Sijie Lin", "@type": "Person"}, {"name": "Yanxiong Chen", "@type": "Person"}, {"name": "Guancan Liang", "@type": "Person"}, {"name": "Youqiang Fang", "@type": "Person"}], "license": "cc-by", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://downloads.hindawi.com/journals/bmri/2017/3941217.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Hindawi Limited", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1155/2017/3941217", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCfh3Bp9274wh-CTcikr1ori59a-CDWWfUbbmzgmW-CRdA9CVPoaLsW", "propertyID": "ISCC"}], "datePublished": "2017-01-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close